SkyBridge Capital II’s Bristol-Myers Squibb BMY Stock Holding History

SkyBridge Capital II’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-52,235	Closed	-$2.37M	–	4
2019 Q2	$2.37M	Buy	+52,235	New	+$2.43M	3.39%	16

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SkyBridge Capital II's BMY Position: Q3 2019 in Review

SkyBridge Capital II sold out of Bristol-Myers Squibb (BMY) in Q3 2019, closing a stake of 52,235 shares — an estimated $2.37M sold.

SkyBridge Capital II first reported a position in BMY in Q2 2019 and held it in 1 quarter. The position peaked at $2.37M in Q2 2019. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

SkyBridge Capital II reported no remaining Bristol-Myers Squibb position as of Q3 2019 after selling out during the quarter.
SkyBridge Capital II sold 52,235 Bristol-Myers Squibb shares in Q3 2019, an estimated $2.37M.
SkyBridge Capital II first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 1 quarter.
SkyBridge Capital II's Bristol-Myers Squibb position peaked at $2.37M in Q2 2019.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on SkyBridge Capital II's 13F filing for Q3 2019.